Studies have shown that decreased levels of APN are present in patients with breast[39], endometrial[40], prostate[41], gastric[42], liver[43], pancreatic[44], hematological[45,46], and colon cancers[47]. This evidence concerns the gene ANPEP and colonic neoplasm.